QA: Blueprint Medicines Corp in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597264_2020_Blueprint_Medicines_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597264, Blueprint Medicines Corp

  xvar xval
0 AssetsCurrent 516,786,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 38,361,000
3 remainder_Assets 152,547,000
4 LiabilitiesCurrent 106,482,000
5 LiabilitiesNoncurrent 136,853,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 338,686,563
9 ResearchAndDevelopmentExpense 770,112,448
10 remainder_Expenses 0
11 remainder_Revenues 84,654,326
12 remainder_NetIncome 20,865,561
13 remainder_ComprehensiveNetIncome 86,100
  yvar yval
0 Assets 707,694,000
1 Liabilities 243,335,000
2 Expenses 1,108,799,011
3 Revenues 84,654,326
4 StockholdersEquity 464,359,000
5 NetIncome -1,003,279,124
6 ComprehensiveNetIncome -1,003,236,074
7 BaseVar 1,082,716,999
8 EconomicCapitalRatiobeforeLimitedLiability 0.0191
9 EconomicCapitalRatio 1.43

Edgar->Model Mapping

Feature Distribution

Change over Time